Loading…
Loading…
EQUITY / NYSE · XNYS
Novo Nordisk A/S Sponsored ADR
No accepted understanding yet. Follow this company to establish research where evidence supports it.
Open research workspace →01/01/2025 – 12/31/2025 · DKK · Units
Reported figures establish facts for this period; they do not by themselves establish a profitability trend.
Open report ↗37.53 USD · 0%
Observed: Oct 6, 2026, 11:55 PM · TickerLayer indicative price; may be delayed
Powered by TickerLayer
10/06/2026 · 37.53 USD · Volume 13,698,725
251 actual observations · Latest bar: 2026-10-06 · Market data is indicative; provider terms apply.
3 available financial reports
Research reports →SEC FINANCIAL REPORTS
01/01/2025 – 12/31/2025 · Units
| Metric | 2025 / Year end | 2024 / Year end | Change |
|---|---|---|---|
| Revenue | 309,064,000,000 DKK | 290,403,000,000 DKK | +6.43% |
| Operating profit | 127,658,000,000 DKK | 128,339,000,000 DKK | -0.53% |
| Net income | 102,434,000,000 DKK | 100,988,000,000 DKK | +1.43% |
| Operating cash flow | 119,102,000,000 DKK | 120,968,000,000 DKK | -1.54% |
| Cash and cash equivalents | 26,464,000,000 DKK | 15,655,000,000 DKK | +69.05% |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2025 / Year end01/01/2025 – 12/31/2025ConsolidatedUnits · DKK | 2024 / Year end01/01/2024 – 12/31/2024ConsolidatedUnits · DKK | 2023 / Year end01/01/2023 – 12/31/2023ConsolidatedUnits · DKK |
|---|---|---|---|
| Cash and cash equivalentsBalance sheet | 26,464,000,000 DKK | 15,655,000,000 DKK | 14,392,000,000 DKK |
| Financing cash flowCash flow statement | -28,408,000,000 DKK | 8,735,000,000 DKK | -63,158,000,000 DKK |
| Gross profitIncome statement | 250,276,000,000 DKK | 245,881,000,000 DKK | 196,496,000,000 DKK |
| Investing cash flowCash flow statement | -79,158,000,000 DKK | -128,895,000,000 DKK | -43,892,000,000 DKK |
| Net incomeIncome statement | 102,434,000,000 DKK | 100,988,000,000 DKK | 83,683,000,000 DKK |
| Operating cash flowCash flow statement | 119,102,000,000 DKK | 120,968,000,000 DKK | 108,908,000,000 DKK |
| Operating profitIncome statement | 127,658,000,000 DKK | 128,339,000,000 DKK | 102,574,000,000 DKK |
| RevenueIncome statement | 309,064,000,000 DKK | 290,403,000,000 DKK | 232,261,000,000 DKK |
| Total assetsBalance sheet | 542,902,000,000 DKK | 465,630,000,000 DKK | — |
| Total equityBalance sheet | 194,047,000,000 DKK | 143,486,000,000 DKK | 106,561,000,000 DKK |
| Total liabilitiesBalance sheet | 348,855,000,000 DKK | 322,144,000,000 DKK | — |
| Report source | Open report ↗ Published: 02/04/2026 | Open report ↗ Published: 02/04/2026 | Open report ↗ Published: 02/04/2026 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.